Gestational diabetes is not an uncommon diagnosis during pregnancy. Recent research published by the American Medical Association suggests rates in the U.S. have increased 36% across all races and ...

Sera Prognostics, Inc. (NASDAQ:SERA) Q4 2025 Earnings Call Transcript March 18, 2026 Sera Prognostics, Inc. beats earnings expectations. Reported EPS is $-0.15768, expectations were $-0.18897.

New research suggests the risks tied to early pregnancy exposure to popular weight loss drugs may not be the same for every patient.

Une femme enceinte asthmatique doit bénéficier d’une prise en charge thérapeutiCorticosteroids and short-acting beta agonists remain the core therapies for pregnant patients with asthma.

The research analysed data from more than 750,000 pregnancies, making it one of the largest studies to examine this issue so far.

Pregnant women with vs. without an asthma biologic prescription had a significantly lower likelihood for adverse pregnancy outcomes, according to findings published in The Journal of Allergy and ...

Welcome to Sera Prognostics fourth quarter and full fiscal year 2025 earnings conference call. At the close of mar ...

If you have not had a chance to review our quarterly earnings release, it can be found on our website at seraprognostics.com.

Emily H. Adhikari, MD, discusses a clinical practice algorithm designed to help clinicians evaluate patients for syphilis.

Weight loss drugs have been linked to an increased risk of premature births among women who took them inadvertently just before or during early pregnancy to treat pre-existing diabetes.

Weight loss drugs have been linked to an increased risk of premature births among women who took them inadvertently just ...

Extends the budget period for the ~$2M total NIH grant funding award for DARE-PTB1 through November 2026• DARE-PTB1 targets preterm birth, for ...